The Microbiome Sequencing Services Market report includes a global opportunity analysis and industry forecasts for the period 2023-2032. The global market was estimated at USD 8.67 Billion in 2022, registering a CAGR of 10.8% from 2023 to 2032. The base year considered for the study is 2021, and the forecast has been provided for the period 2023 to 2032.
The microbiome sequencing services market is expected to experience significant growth in the coming years due to the increasing demand for personalized medicine and the growing awareness of the importance of the microbiome in human health. In addition, increasing focus on human microbiome therapy as new validated target for drug development, rising investment in microbiome research, growing interest in understanding role of microbiome in human health are some factors driving the microbiome sequencing services market. Furthermore, increasing the incidence of colorectal cancer (CRC) globally can also increase the demand for the microbiome sequencing services. For instance, as per a 2019 report by the International Agency for Research on Cancer, the incidence of colon cancer is expected to increase from nearly 1.1 million in 2019 to over 1.5 million by 2030. Moreover, rise in the healthcare expenditure and the infrastructure can drives the growth of the microbiome sequencing services. The market is segmented by technology, application, end-user, and region.
Figure 1: Microbiome Sequencing Services Market
By technology, the market is segmented into Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), Pyrosequencing, Sanger Sequencing, and other technologies. Sanger Sequencing is expected to hold the largest market share during the forecast period. However, the other technologies are also expected to experience significant growth due to their increasing adoption and technological advancements.
By application, the market is segmented into Shotgun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Whole Genome Sequencing. Shotgun sequencing is expected to continue to hold the largest market share due to its ability to analyze complex microbial communities and its use in metagenomic sequencing. However, the other segments are also expected to experience significant growth as more research is conducted on the microbiome's role in various health conditions.
By end-user, the market is segmented into Pharmaceutical and Biotechnology Companies. The pharmaceutical and biotechnology companies’ segment is expected to hold the largest market share due to the increasing investment in microbiome research by these companies. The academic and research institutes segment is also expected to experience significant growth due to the increasing research on the microbiome and its potential applications.
Impact factors:
- Growing awareness of personalized medicine
- Increasing prevalence of chronic diseases
- Increasing investments in the field of microbiome sequencing
Key Drivers:
- Increased focus on human microbiome therapy
- Human microbiome as new validated target for drug development
- Human microbiome for early disease detection and diagnosis
Restraints:
- Lack of expertise and detailed research
- Barriers in proving the causal link between dysbiosis and disease
By region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America. North America is expected to hold the largest market share due to the presence of key players in the region and the increasing investment in microbiome research. However, the other regions are also expected to experience significant growth due to the increasing awareness of the importance of the microbiome in human health and the growing demand for personalized medicine.
Recent Developments:
- In March 2022, Diversigen, a subsidiary of Orasure Technologies, launches metatranscriptomic sequencing and analysis services for gut microbiome samples.
- In January 2022, Eagle Genomics and Quadram Institute have formed a new strategic alliance to speed microbiome analysis using an AI-augmented knowledge discovery platform.
Market Segmentation:
By Technology
- Sequencing By Synthesis (SBS)
- Sequencing By Ligation (SBL)
- Pyrosequencing
- Sanger Sequencing
By Application
- Shotgun Sequencing
- Targeted Gene Sequencing
- RNA Sequencing
- Whole Genome Sequencing
By Research Type
- Outsourced
- Internal
By Laboratory Type
- Wet Labs
- Dry Labs
By End User
- Pharmaceutical
- Biotechnology Companies
Regional Coverage:
- North America
-
- US
- Canada
- Mexico
- Europe
-
- Germany
- Russia
- UK
- France
- Italy
- Spain
- The Netherlands
- Rest of Europe
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Rest of Asia Pacific
- Middle East & Africa
-
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
- South America
-
- Brazil
- Argentina
- Colombia
- Rest of South America
Key Players:
The key players operating the global Microbiome Sequencing Services market, which are playing a major role in market development have been studied extensively in this report are Clinical Microbiomics AS, Baseclear B.V., Metabiomics Corp., Microbiome Insights Inc, Microbiome Therapeutics, LLC, MR DNA, Merieux Nutrisciences Corporation, Ubiome, Inc., Zymo Research Corp, Second Genome.
Competitive Landscape:
Company overview, latest trends, financials, R&D expenditures, and SWOT analysis are some of the key features of the competitive analysis provided in this study.
Years Covered in the Study:
Historic Year: 2019-2020
Base Year: 2021
Estimated Year: 2022
Forecast Year: 2032
Objectives of this report:
- To estimate market size on regional and global basis.
- To identify major segments in the market and evaluate their market shares and demand.
- To provide a competitive scenario for the market with major developments observed by key companies in the historic years.
- To evaluate key factors governing the dynamics of the market with their potential gravity during the forecast period.
Reasons to Buy This Report:
- Technical Market definition of the global market along with the analysis of different influencing factors like drivers, restraints, and opportunities.
- Extensive research on the competitive landscape of more than 25+ Global as well as regional companies.
- Identification and analysis of micro and macro factors that are and will affect the growth of the market.
- A descriptive analysis of demand-supply gap, estimation and forecast in the global market.
- Statistical analysis of some significant economic factors.
- Partner Identification in the Supply Chain.
- 200+ Figures, charts, graphs, and pictures describe the market clearly.
- Historical and estimated Pricing Analysis of the market considered as part of scope.
Key Questions Answered in this Report:
- What is the market size and growth rate of the global and regional market by various segments?
- Market size and growth rate of the market for selective countries?
- Which region or sub segment is expected to drive the market in the forecast period?
- What are the driving factors as well as restraints in the market growth?
- How the technological shift and disruptions are helping market to grow?
- What are the key opportunities in the market?
- Which company accounted or will account for the highest market share in 2021, 2022, and 2023?
- Which are the key companies operating in the market?
Customization:
This study is customized to meet your specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
- Product Specific Competitive Analysis
- Company profiling
- Client’s comparison vs others
For more information, contact: sales@quincemarketinsights.com